Close

Dangdai International Makes $43.1M Strategic Investment in Cellular Biomedicine Group (CBMG)

April 19, 2016 8:33 AM EDT Send to a Friend
Cellular Biomedicine Group Inc. (Nasdaq: CBMG) announced the final closing of Wuhan Dangdai Science and Technology Industries Group Inc.’s (“DANGDAI”) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login